DexCom Inc (NAS:DXCM)
$ 129.71 3.74 (2.97%) Market Cap: 51.58 Bil Enterprise Value: 49.79 Bil PE Ratio: 83.68 PB Ratio: 22.88 GF Score: 89/100

DexCom Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 09, 2020 / 08:20PM GMT
Release Date Price: $100.42 (+3.21%)
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right, guys. I think we are live. I'm just trying to get my screens set over to my laptop, and there I go. I'm good. So good afternoon, everyone. Sorry, a little technical difficulty there. But I think we'll get started. My name is Jeff Johnson. I'm the Senior Medical Technology Analyst at Baird. Our next presentation this afternoon is from DexCom, a continuous glucose monitor manufacturer that currently enjoys a leading share of the nearly $4 billion global CGM market. With us today from DexCom, we're pleased to have Executive Vice President of Strategy and Corporate Development, Steve Pacelli; and Senior Vice President of Finance and Chief Accounting Officer, Jereme Sylvain. So guys, I think we're just going to go straight into Q&A, and we're running a couple of minutes behind, so why don't we just do that. So thank you for joining us. It's good to see you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot